Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (259) 259
humans (183) 183
male (156) 156
cholesterol (153) 153
female (132) 132
animals (128) 128
mice (100) 100
cholesterol - metabolism (98) 98
biochemistry & molecular biology (92) 92
middle aged (76) 76
cholesterol - blood (73) 73
aged (69) 69
lipids (67) 67
phytosterols (66) 66
adult (63) 63
atherosclerosis (59) 59
metabolism (55) 55
brain - metabolism (53) 53
brain (48) 48
plant sterols (46) 46
mice, inbred c57bl (45) 45
mice, knockout (44) 44
sterols (42) 42
liver - metabolism (41) 41
neurosciences (40) 40
physiological aspects (36) 36
phytosterols - blood (36) 36
analysis (35) 35
oxysterols (33) 33
diet (32) 32
cholesterol - analogs & derivatives (31) 31
homeostasis (31) 31
plasma (31) 31
alzheimer's disease (29) 29
24s-hydroxycholesterol (28) 28
absorption (28) 28
risk factors (28) 28
alzheimers-disease (26) 26
apolipoproteins e - genetics (26) 26
disease models, animal (26) 26
hydroxycholesterols - blood (26) 26
lipoproteins (26) 26
rodents (26) 26
atp-binding cassette transporters - genetics (25) 25
biomarkers - blood (25) 25
cholesterol - biosynthesis (25) 25
dietary-cholesterol (25) 25
abridged index medicus (24) 24
aged, 80 and over (24) 24
article (24) 24
cardiac & cardiovascular systems (24) 24
cell biology (24) 24
inflammation (24) 24
liver (24) 24
mice, transgenic (24) 24
multidisciplinary sciences (23) 23
nutrition & dietetics (23) 23
phytosterols - metabolism (23) 23
disease (22) 22
pharmacology & pharmacy (22) 22
alzheimer disease - genetics (21) 21
hydroxycholesterols - metabolism (21) 21
research (21) 21
sitosterols - blood (21) 21
expression (20) 20
lathosterol (20) 20
lipid metabolism (20) 20
macrophages (20) 20
sitosterol (20) 20
time factors (20) 20
apolipoprotein e (19) 19
cholesterol absorption (19) 19
cholesterol homeostasis (19) 19
hypercholesterolemia (19) 19
nutrition (19) 19
peripheral vascular disease (19) 19
sitosterolemia (19) 19
anticholesteremic agents (18) 18
bile (18) 18
cardiovascular (18) 18
double-blind method (18) 18
endocrinology & metabolism (18) 18
neurology (18) 18
research article (18) 18
adolescent (17) 17
apolipoproteins (17) 17
cells, cultured (17) 17
central-nervous-system (17) 17
cholesterol synthesis (17) 17
cholesterol, ldl - blood (17) 17
coronary-heart-disease (17) 17
in-vitro (17) 17
risk (17) 17
alzheimer disease - metabolism (16) 16
amyloid precursor protein (16) 16
apolipoprotein-e (16) 16
biophysics (16) 16
case-control studies (16) 16
cholesterol metabolism (16) 16
circulation (16) 16
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Vascular Effects of Diet Supplementation With Plant Sterols
by Weingärtner, Oliver, MD and Lütjohann, Dieter, PhD and Ji, Shengbo and Weisshoff, Nicole and List, Franka and Sudhop, Thomas, MD and von Bergmann, Klaus, MD and Gertz, Karen, MD and König, Jochem, PhD and Schäfers, Hans-Joachim, MD and Endres, Matthias, MD and Böhm, Michael, MD and Laufs, Ulrich, MD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2008, Volume 51, Issue 16, pp. 1553 - 1561
Vascular Effects of Diet Supplementation With Plant Sterols Oliver Weingärtner, Dieter Lütjohann, Shengbo Ji, Nicole Weisshoff, Franka List, Thomas Sudhop,... 
Cardiovascular | Internal Medicine | PHYTOSTEROLS | CARDIAC & CARDIOVASCULAR SYSTEMS | PLASMA | HYPERCHOLESTEROLEMIC SUBJECTS | ATHEROSCLEROSIS | SERUM | DEFICIENT MICE | CORONARY HEART-DISEASE | ASSOCIATION | NONCHOLESTEROL STEROLS | INTESTINAL CHOLESTEROL ABSORPTION | Humans | Mice, Inbred C57BL | Risk Factors | Arteriosclerosis - physiopathology | Male | Brain Ischemia - physiopathology | Brain Ischemia - prevention & control | Cardiovascular System - drug effects | Endothelium - physiopathology | Phytosterols - pharmacology | Arteriosclerosis - prevention & control | Phytosterols - administration & dosage | Animals | Phytosterols - blood | Plant Preparations | Female | Aged | Mice | Dietary Supplements | Brain | Esters | Analysis | Injuries | Phytosterols | Endothelium | Plasma | Sterols | Ischemia | Diet | Rodents | Atherosclerosis | Brain damage | Cardiovascular disease | Smooth muscle | Cholesterol | Functional foods & nutraceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3
by De Nardo, Dominic and Labzin, Larisa I and Kono, Hajime and Seki, Reiko and Schmidt, Susanne V and Beyer, Marc and Xu, Dakang and Zimmer, Sebastian and Lahrmann, Catharina and Schildberg, Frank A and Vogelhuber, Johanna and Kraut, Michael and Ulas, Thomas and Kerksiek, Anja and Krebs, Wolfgang and Bode, Niklas and Grebe, Alena and Fitzgerald, Michael L and Hernandez, Nicholas J and Williams, Bryan R.G and Knolle, Percy and Kneilling, Manfred and Röcken, Martin and Lütjohann, Dieter and Wright, Samuel D and Schultze, Joachim L and Latz, Eicke
Nature Immunology, ISSN 1529-2908, 02/2014, Volume 15, Issue 2, pp. 152 - 160
High-density lipoprotein (HDL) mediates reverse cholesterol transport and is known to be protective against atherosclerosis. In addition, HDL has potent... 
HDL | TOLL-LIKE-RECEPTOR-4 | ACTIVATION | CHOLESTEROL | VIVO | RECOGNITION | LIPID RAFTS | ATHEROSCLEROSIS | MICE | IMMUNOLOGY | INFLAMMATORY RESPONSE | Humans | Gene Expression Profiling | Systems Biology | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Lipoproteins, HDL - pharmacology | Atherosclerosis - therapy | Chromatin Immunoprecipitation | Lipoproteins, HDL - therapeutic use | Female | Macrophages - immunology | Activating Transcription Factor 3 - genetics | Mice, Inbred C57BL | Cells, Cultured | Cytokines - secretion | Toll-Like Receptor 4 - genetics | Toll-Like Receptor 4 - immunology | Cholesterol - metabolism | Activating Transcription Factor 3 - metabolism | Mice, Inbred C3H | Inflammation - therapy | Animals | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Macrophages - drug effects | High-Throughput Nucleotide Sequencing | Mice | Macrophage Activation - drug effects | Care and treatment | High density lipoproteins | Atherosclerosis | Physiological aspects | Genetic aspects | Research | Macrophages | Health aspects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Personalize and Optimize Lipid-Lowering Therapies
by Weingärtner, Oliver, MD and Lütjohann, Dieter, PhD and Elsässer, Albrecht, MD
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 3, pp. 325 - 326
  (4) observed rapid atheroma progression in hyporesponders to statin therapy, and the PRECISE-IVUS study (Plaque Regression With Cholesterol Absorption... 
Cardiovascular | Internal Medicine | CARDIAC & CARDIOVASCULAR SYSTEMS | Anticholesteremic agents | Cardiovascular agents | Cardiovascular disease | Lipids | Acute coronary syndromes | Low density lipoprotein | Statins | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Inhibition of intestinal cholesterol absorption by ezetimibe in humans
by Sudhop, T and Lutjohann, D and Kodal, A and Igel, M and Tribble, DL and Shah, S and Perevozskaya, I and von Bergmann, K
CIRCULATION, ISSN 0009-7322, 10/2002, Volume 106, Issue 15, pp. 1943 - 1948
Background-Ezetimibe has been shown to inhibit cholesterol absorption in animal models, but studies on cholesterol absorption in humans have not been performed... 
CARDIAC & CARDIOVASCULAR SYSTEMS | cholesterol synthesis | STEROLS | DENSITY-LIPOPROTEIN CHOLESTEROL | PLASMA | A-REDUCTASE INHIBITORS | METABOLISM | ezetimibe | cholesterol absorption | plant sterols | PERIPHERAL VASCULAR DISEASE | NEOMYCIN | SCH58235 | HEMATOLOGY | lathosterol | Hypercholesterolemia - blood | Double-Blind Method | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Intestinal Absorption - drug effects | Male | Azetidines - pharmacology | Lipoproteins - blood | Cholesterol - metabolism | Sterols - blood | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Cross-Over Studies | Anticholesteremic Agents - therapeutic use | Azetidines - therapeutic use | Adult | Cholesterol - biosynthesis | Hypercholesterolemia - metabolism | Anticholesteremic Agents - pharmacology | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Proinflammatory stimulation of toll-like receptor 9 with high dose CpG ODN 1826 impairs endothelial regeneration and promotes atherosclerosis in mice
by Krogmann, Alexander O and Lüsebrink, Enzo and Steinmetz, Martin and Asdonk, Tobias and Lahrmann, Catharina and Lütjohann, Dieter and Nickenig, Georg and Zimmer, Sebastian
PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, pp. e0146326 - e0146326
Background Toll-like receptors (TLR) of the innate immune system have been closely linked with the development of atherosclerotic lesions. TLR9 is activated by... 
SYSTEMIC INFLAMMATION | ACTIVATION | DENDRITIC CELLS | CHOLESTEROL | DNA | MACROPHAGES | MULTIDISCIPLINARY SCIENCES | TLR9 | CARDIAC DYSFUNCTION | OLIGODEOXYNUCLEOTIDE | INNATE IMMUNITY | Carotid Arteries - metabolism | Immunohistochemistry | Body Weight | Reactive Oxygen Species - metabolism | Atherosclerosis - genetics | Humans | DNA, Single-Stranded - genetics | Inflammation - metabolism | Flow Cytometry | Oligodeoxyribonucleotides - genetics | Cell-Derived Microparticles - metabolism | Disease Models, Animal | Cytokines - metabolism | Atherosclerosis - physiopathology | Mice, Inbred C57BL | Cells, Cultured | Vascular Diseases - genetics | Mice, Transgenic | Atherosclerosis - metabolism | Aorta - pathology | Regeneration | Animals | Spleen - metabolism | Endothelium, Vascular - metabolism | Apolipoproteins E - genetics | Mice | Oligodeoxyribonucleotides - pharmacology | Toll-Like Receptor 9 - metabolism | Vascular Diseases - metabolism | Complications and side effects | Care and treatment | Cytokines | Patient outcomes | Atherosclerosis | Development and progression | Research | Apolipoproteins | Reactive oxygen species | Oligonucleotides | Smooth muscle | Stimulation | Carotid arteries | Microparticles | Proteins | Signal transduction | Receptors | Vascular diseases | Apolipoprotein E | Rodents | Denudation | Toll-like receptors | Aorta | Lesions | Vascular endothelial growth factor receptor 2 | Deoxyribonucleic acid--DNA | Immune system | CpG islands | Inflammation | Nucleic acids | Cholesterol | TLR9 protein | Immune systems | Arteriosclerosis | Ligands | Apoptosis | Veins & arteries | Index Medicus | Deoxyribonucleic acid
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells
by Bieghs, Veerle and Verheyen, Fons and van Gorp, Patrick J and Henikx, Tim and Wouters, Kristiaan and Lütjohann, Dieter and Gijbels, Marion J. J and Febbraio, Maria and Binder, Christoph J and Hofker, Marten H and Shiri-Sverdlov, Ronit
PLoS ONE, ISSN 1932-6203, 2012, Volume 7, Issue 3, pp. e34378 - 7 p.
Non-alcoholic steatohepatitis (NASH) is characterized by steatosis and inflammation, which can further progress into fibrosis and cirrhosis. Recently, we... 
LDL | SCAVENGER RECEPTOR CD36 | MULTIDISCIPLINARY SCIENCES | DISEASE | ATHEROSCLEROSIS | ACCUMULATION | PROTECTS | Inflammation - pathology | Kupffer Cells - pathology | CD36 Antigens - deficiency | Liver - pathology | CD36 Antigens - genetics | Fatty Liver - pathology | Lipids - chemistry | Lysosomes - metabolism | CD36 Antigens - metabolism | Bone Marrow Transplantation | Non-alcoholic Fatty Liver Disease | Receptors, LDL - deficiency | Female | Scavenger Receptors, Class A - genetics | Kupffer Cells - metabolism | Receptors, LDL - genetics | Fatty Liver - metabolism | Liver - metabolism | Scavenger Receptors, Class A - deficiency | Receptors, LDL - metabolism | Lipid Metabolism | Cholesterol - metabolism | Mice, Knockout | Animals | Mice | Scavenger Receptors, Class A - metabolism | Lipids | Inflammation | Macrophages | Liver cirrhosis | Cholesterol | Syngeneic grafts | Trafficking | Liver | Kupffer cells | Bone marrow transplantation | Acidification | Homeostasis | Inflammatory response | Biology | Autophagy | Accumulation | Liver cancer | Signal transduction | Receptors | Toxicology | Clonal deletion | Rodents | Atherosclerosis | Deletion | Bone marrow | Scavenger receptors | Lipoprotein (low density) receptors | Liver diseases | CD36 antigen | Steatosis | Nutrition research | Pathology | Cirrhosis | Lipoproteins | Microscopy | Internalization | Fibrosis | Intracellular | Laboratory animals | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text High Fat Diet Exacerbates Neuroinflammation in an Animal Model of Multiple Sclerosis by Activation of the Renin Angiotensin System
by Timmermans, Silke and Bogie, Jeroen F. J and Vanmierlo, Tim and Lütjohann, Dieter and Stinissen, Piet and Hellings, Niels and Hendriks, Jerome J. A
Journal of Neuroimmune Pharmacology, ISSN 1557-1890, 3/2014, Volume 9, Issue 2, pp. 209 - 217
Epidemiological studies suggest a positive correlation between the incidence and severity of multiple sclerosis (MS) and the intake of fatty acids. It remains... 
Neurosciences | Renin angiotensin system | Biomedicine | Immunology | Experimental autoimmune encephalomyelitis | Inflammation | Pharmacology/Toxicology | Virology | Cell Biology | High fat diet | VITAMIN-D | OXIDATIVE STRESS | CHOLESTEROL | ACIDS | NEUROSCIENCES | PATHOGENESIS | OBESITY | METABOLISM | PHARMACOLOGY & PHARMACY | NUTRITION | EXPRESSION | Immunohistochemistry | Encephalomyelitis, Autoimmune, Experimental - pathology | Encephalomyelitis, Autoimmune, Experimental - metabolism | Mice, Inbred C57BL | Diet, High-Fat - adverse effects | Encephalomyelitis, Autoimmune, Experimental - immunology | Renin-Angiotensin System - physiology | Animals | Multiple Sclerosis - immunology | Multiple Sclerosis - pathology | Female | Mice | Real-Time Polymerase Chain Reaction | Disease Models, Animal | Multiple Sclerosis - metabolism | Autoimmunity | Multiple sclerosis | Fatty acids | Analysis | Angiotensin | Diet | Rodents | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease
by Bieghs, Veerle and van Gorp, Patrick J and Wouters, Kristiaan and Henikx, Tim and Gijbels, Marion J and van Bilsen, Marc and Bakker, Jaap and Binder, Christoph J and Lütjohann, Dieter and Staels, Bart and Hofker, Marten H and Shiri-Sverdlov, Ronit
PLoS ONE, ISSN 1932-6203, 2012, Volume 7, Issue 1, pp. e30668 - 11 p.
Non-alcoholic steatohepatitis (NASH) involves steatosis combined with inflammation, which can progress into fibrosis and cirrhosis. Exploring the molecular... 
SCAVENGER RECEPTOR | IN-VIVO | BIOLOGY | LOW-DENSITY-LIPOPROTEIN | ANIMAL-MODELS | ATHEROSCLEROSIS | STEATOHEPATITIS | DEFICIENT MICE | HEPATIC STEATOSIS | MOUSE MODELS | APOLIPOPROTEIN-E | Liver - pathology | Fatty Liver - pathology | Cholesterol - blood | Humans | Fatty Liver - complications | Diet, High-Fat - adverse effects | Apoptosis - genetics | Male | Inflammation - complications | Time Factors | Non-alcoholic Fatty Liver Disease | Receptors, LDL - deficiency | Lipoproteins, LDL - metabolism | Hyperlipidemias - complications | Disease Models, Animal | Fatty Liver - genetics | Receptors, LDL - genetics | Kupffer Cells - cytology | Apolipoprotein E2 - genetics | Bone Marrow Cells - cytology | Liver Cirrhosis - complications | Liver - metabolism | Mice, Inbred C57BL | Gene Expression Regulation | Cholesterol - metabolism | Gene Knockout Techniques | Gene Knock-In Techniques | Animals | Fatty Liver - immunology | Mice | Medical research | Low density lipoproteins | Physiological aspects | Medicine, Experimental | Inflammation | Liver cirrhosis | Cholesterol | Lipoproteins (low density) | Animal models | Liver | Inflammatory response | Cytotoxicity | Arthritis | Macrophages | Metabolic syndrome | Toxicology | Fatty liver | Rodents | Hydrofluorocarbons | Atherosclerosis | Bone marrow | Genetics | Lipoprotein (low density) receptors | Physiology | Damage | Liver diseases | Cytokines | Apolipoproteins | Low density lipoprotein | Feeding | Steatosis | Nutrition research | Pathology | Cirrhosis | Molecular modelling | Fibrosis | Insulin resistance | Laboratory animals | Binding sites | Apoptosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Defective cholesterol clearance limits remyelination in the aged central nervous system
by Cantuti-Castelvetri, Ludovico and Fitzner, Dirk and Bosch-Queralt, Mar and Weil, Marie-Theres and Su, Minhui and Sen, Paromita and Ruhwedel, Torben and Mitkovski, Miso and Trendelenburg, George and Lütjohann, Dieter and Möbius, Wiebke and Simons, Mikael
Science, ISSN 0036-8075, 02/2018, Volume 359, Issue 6376, pp. 684 - 688
Age-associated decline in regeneration capacity limits the restoration of nervous system functionality after injury. In a model for demyelination, we found... 
CELLS | LIVER X RECEPTORS | MULTIPLE-SCLEROSIS | CNS REMYELINATION | MICROGLIA | MACROPHAGES | MULTIDISCIPLINARY SCIENCES | DIFFERENTIATION | APOLIPOPROTEIN-E | Central Nervous System - metabolism | Lysosome-Associated Membrane Glycoproteins - metabolism | Myelin Sheath - pathology | Crystallization | Phagocytes - metabolism | Cholesterol - metabolism | Demyelinating Diseases - metabolism | Apolipoproteins E - metabolism | Mice, Knockout | Myelin Sheath - metabolism | Central Nervous System - physiology | Animals | Aging - physiology | Apolipoproteins E - genetics | Mice | Remyelination | Aging - metabolism | Physiological aspects | Observations | Cholesterol metabolism | Central nervous system | Drugs | Multiple sclerosis | Immune clearance | Inflammatory response | Stimulation | Nervous system | Regeneration (physiology) | Immunosuppressive agents | Phagocytes | Restoration | Sheaths | Demyelination | Apolipoprotein E | Atherosclerosis | Aging | Lesions | Damage accumulation | Debris | Efflux | Immune response | Phase transformations | Myelin | Tissue engineering | Rupture | Detritus | Crystals | Inflammation | Apolipoproteins | Cholesterol | Immune systems | Medicine | Regeneration | Myelination | Injury prevention | Arteriosclerosis | Phase transition | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Acute Intake of Plant Stanol Esters Induces Changes in Lipid and Lipoprotein Metabolism-Related Gene Expression in the Liver and Intestines of Mice
by De Smet, Els and Mensink, Ronald P and Konings, Maurice and Brufau Dones, Gemma and Groen, Albert K and Havinga, Rick and Schonewille, Marleen and Kerksiek, Anja and Luetjohann, Dieter and Plat, Jogchum
Lipids, ISSN 0024-4201, 06/2015, Volume 50, Issue 6, pp. 529 - 541
The kinetics of plant stanol uptake and routing in 8-week-old C57BL/6J mice were determined after a plant stanol ester gavage. In addition, acute changes in... 
Neurochemistry | Intestines | Nutrition | Medical Biochemistry | Lipids | Gene expression | Cholesterol | Life Sciences | Medicinal Chemistry | Lipidology | Lipoproteins | Microbial Genetics and Genomics | Lymph canulation | Plant stanols | TRANSPORTER | BIOCHEMISTRY & MOLECULAR BIOLOGY | STEROLS | HUMANS | ANTIBODY | EZETIMIBE | CHOLESTEROL ABSORPTION | PHYTOSTEROLS | NUTRITION & DIETETICS | INHIBITION | REDUCTASE | SECRETION | Animals, Newborn | Gene Expression | Sitosterols - blood | Cholesterol - blood | Liver - metabolism | Mice, Inbred C57BL | Proprotein Convertases - metabolism | Receptors, LDL - metabolism | Lipid Metabolism | Male | Intestines - metabolism | Cholesterol - metabolism | Orphan Nuclear Receptors - metabolism | RNA, Messenger - metabolism | Sitosterols - pharmacokinetics | Cholesterol - genetics | Animals | Liver X Receptors | Lipoproteins - metabolism | Female | Serine Endopeptidases - metabolism | Sterol Regulatory Element Binding Protein 2 - metabolism | Proprotein Convertase 9 | Proteolipids | Liver | Esters | Genetic aspects | Lipid metabolism | Blood lipoproteins | Health aspects | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Monocytic microparticles promote atherogenesis by modulating inflammatory cells in mice
by Hoyer, Friedrich Felix and Giesen, Meike Kristin and Nunes França, Carolina and Lütjohann, Dieter and Nickenig, Georg and Werner, Nikos
Journal of Cellular and Molecular Medicine, ISSN 1582-1838, 11/2012, Volume 16, Issue 11, pp. 2777 - 2788
Microparticles ( MP ) are generated during a vast number of biological processes such as inflammation, cell activation and apoptosis. Increasing evidence... 
vascular inflammation | monocytic microparticles atherosclerosis | Monocytic microparticles atherosclerosis | Vascular inflammation | MEDICINE, RESEARCH & EXPERIMENTAL | PROCOAGULANT | ACTIVATE | ENHANCE | ENDOTHELIAL-CELLS | MICROVESICLES | APOPTOTIC BODIES | CELL BIOLOGY | Blood Pressure | Macrophages - physiology | Heart Rate | T-Lymphocytes - physiology | Vasculitis - metabolism | Reactive Oxygen Species - metabolism | Atherosclerosis - physiopathology | Endothelial Cells - metabolism | Cholesterol - blood | Vasculitis - pathology | Cells, Cultured | Diet, High-Fat - adverse effects | Apolipoproteins E - metabolism | Atherosclerosis - metabolism | Collagen - metabolism | Intercellular Adhesion Molecule-1 - metabolism | Receptors, CCR2 - metabolism | Animals | Mice, Mutant Strains | Apolipoproteins E - genetics | Mice | Monocytes - physiology | Interleukin-6 - metabolism | Cell Movement | Cholesterol | Molecules | Diet | Rodents | Cells | Cell adhesion & migration | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Need to individualise cholesterol-lowering therapy
by Lütjohann, Dieter and Weingärtner, Oliver
Heart, ISSN 1355-6037, 08/2019, Volume 105, Issue 16, pp. 1291 - 1292
CARDIAC & CARDIOVASCULAR SYSTEMS | Statins | Cholesterol | Atherosclerosis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Oxysterols: Players in different metabolic leagues
by Lütjohann, Dieter and Lizard, Gérard and Iuliano, Luigi
Journal of Steroid Biochemistry and Molecular Biology, ISSN 0960-0760, 05/2017, Volume 169, pp. 1 - 3
DISEASES | BIOCHEMISTRY & MOLECULAR BIOLOGY | BRAIN | STEROLS | ENDOCRINOLOGY & METABOLISM | Congresses as Topic | Inflammation Mediators | Metabolic Diseases - therapy | Animals | Metabolic Diseases - etiology | Humans | Cholesterol - metabolism | Oxysterols - metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans
by Bonde, Ylva and Breuer, Olof and Lütjohann, Dieter and Sjöberg, Stefan and Angelin, Bo and Rudling, Mats
Journal of Lipid Research, ISSN 0022-2275, 11/2014, Volume 55, Issue 11, pp. 2408 - 2415
Reduced plasma LDL-cholesterol is a hallmark of hyperthyroidism and is caused by transcriptional stimulation of LDL receptors in the liver. Here, we... 
Fibroblast growth factor | Fibroblast growth factor 21 | Lipoproteins/metabolism | Cholesterol/absorption | Drug therapy/hypolipidemic drugs | Eprotirome | Proprotein convertase subtilisin/kexin type 9 | Cholesterol 7alpha-hydroxylase | Fibroblast growth factor 19 | Bile acids and salts/biosynthesis | cholesterol 7alpha-hydroxylase | fibroblast growth factor 21 | proprotein convertase subtilisin/kexin type 9 | eprotirome | bile acids and salts/biosynthesis | BIOCHEMISTRY & MOLECULAR BIOLOGY | KEXIN TYPE 9 | A-IV | HMG-COA REDUCTASE | cholesterol/absorption | drug therapy/hypolipidemic drugs | HEPATIC CHOLESTEROL 7-ALPHA-HYDROXYLASE | MESSENGER-RNA LEVELS | HYPOPHYSECTOMIZED RATS | fibroblast growth factor | PLASMA | SERUM LEVELS | DIURNAL-VARIATION | lipoproteins/metabolism | GROWTH-FACTOR 21 | fibroblast growth factor 19 | Bile Acids and Salts - blood | Cholesterol - blood | Humans | Middle Aged | Bile Acids and Salts - chemistry | Intestinal Absorption - drug effects | Hyperthyroidism - metabolism | Male | Apolipoproteins B - blood | Insulin - blood | Young Adult | Liver - drug effects | Body Composition - drug effects | Adult | Female | Proprotein Convertases - blood | Lipoprotein(a) - blood | Hyperthyroidism - enzymology | Bile Acids and Salts - biosynthesis | Hyperthyroidism - blood | Liver - metabolism | Receptors, Thyroid Hormone - agonists | Fibroblast Growth Factor 9 - blood | Fibroblast Growth Factors - blood | Thyroid Hormones - metabolism | Serine Endopeptidases - blood | Adolescent | Anilides - pharmacology | Aged | Blood Glucose - metabolism | Proprotein Convertase 9 | Index Medicus | kexin type 9 | Patient-Oriented and Epidemiological Research | proprotein convertase subtilisin | drug therapy | absorption | hypolipidemic drugs | biosynthesis | bile acids and salts | cholesterol | metabolism | lipoproteins
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights